Publications by authors named "Eva Alcoceba"

Neisseria gonorrhoeae exhibits alarming antibiotic resistance trends and poses a significant challenge in therapeutic management. This study aimed to explore the association of penA alleles with penicillin-binding protein (PBP) occupancy patterns and reduced outer membrane permeability, impacting susceptibility to last-line cephalosporins and potential β-lactam candidates. The whole genome sequence, the MICs and PBP IC50s were determined for 12 β-lactams and β-lactamase inhibitors in 8 clinical isolates with varying β-lactam sensitivity, 2 ATCC, and 3 WHO cephalosporin-resistant reference strains.

View Article and Find Full Text PDF
Article Synopsis
  • This study aims to quickly and accurately detect the Y132F ERG11p mutation in Candida parapsilosis isolates and to analyze genetic diversity among these isolates for better tracking of fluconazole resistance.!* -
  • The research involved 223 isolates from patients across 20 hospitals in Spain and Italy, using newly optimized PCR methods that require no DNA extraction and provide results in as little as 1.5 hours.!* -
  • The findings confirm both PCR methods have 100% specificity and sensitivity, with Scheme 1 showing greater genetic diversity compared to Scheme 2, suggesting the use of specific microsatellite markers for better genotyping of resistant strains.!*
View Article and Find Full Text PDF

Background: Fluconazole-resistant Candida parapsilosis is a matter of concern.

Objectives: To describe fluconazole-resistant C. parapsilosis genotypes circulating across hospitals in Spain and Rome and to study their azole-resistance profile associated with ERG11p substitutions.

View Article and Find Full Text PDF
Article Synopsis
  • Candidemia, often linked to medical implants, has seen rising cases of fluconazole-resistant strains in Spain, particularly during the COVID-19 pandemic.
  • A study analyzed 1,315 yeast isolates from 2000 to 2021, revealing increased instances of acquired resistance to fluconazole and voriconazole in various Spanish hospitals.
  • Three prevalent clones were identified, with a need for further research to understand their expansion and genetic connections.
View Article and Find Full Text PDF

We have been monitoring the antifungal resistance in Candida parapsilosis isolates collected from inpatients at Madrid metropolitan area hospitals for the last 3 years. The study aimed to elucidate the presence of fluconazole-resistant C. parapsilosis genotypes in Madrid.

View Article and Find Full Text PDF

Objectives: We report here for the first time the presence of Candida parapsilosis isolates harbouring the Y132F ERG11 gene substitution in patients admitted to a Spanish hospital.

Methods: We studied the available (n = 104) C parapsilosis isolates from patients admitted to the Son Espases reference hospital in the Balearic Islands from 1 April 2019 to 30 November 2020. Isolates were sourced from 70 patients: catheter (n = 41), blood cultures (n = 37), lower respiratory tract (n = 15), intra-abdominal (n = 8), and other samples (n = 3).

View Article and Find Full Text PDF
Article Synopsis
  • * Over 2,500 gonococcal isolates were tested; the resistance rates were very low for extended-spectrum cephalosporins (0.2% for ceftriaxone and 1.7% for cefixime), while azithromycin showed a higher resistance rate of 12.1%.
  • * The findings suggest that while susceptibility to cephalosporins is high, the notable azithromycin resistance raises concerns about dual therapy effectiveness; the study emphasizes the need for a national program to monitor NG resistance
View Article and Find Full Text PDF

According to recent literature, 95.4% of the strains associated with human clinical cases correspond to four species: , , and However, other less prevalent species such as are also described from clinical samples. Based on its low incidence, the latter species can be regarded as rare and it is the only species susceptible to ampicillin.

View Article and Find Full Text PDF

Introduction: Human Metapneumovirus (hMPV) was first identified in 2001 in respiratory samples from children and adults with acute respiratory tract infection. The aim of this prospective study was to determine the clinical and epidemiological characteristics of pediatric patients with an acute respiratory tract infection and exclusive isolation of hMPV in respiratory samples (December 2005-January 2007).

Material And Methods: All respiratory tract samples were submitted to rapid antigen detection against respiratory syncytial virus (RSV) and influenza A and B viruses.

View Article and Find Full Text PDF

We report a prospective study concerning the efficacy of LLC-MK2 (continuous monkey kidney cell), Hep-2, MDCK (Madin-Darby Canine Kidney), Vero and MRC-5 cell lines, by shell vial assay, and incubation time in the isolation of hMPV from pediatric respiratory samples. The overall sensitivity of the cell lines studied were: 100% for the LLC-MK2, 68.7% for the Hep-2, 28.

View Article and Find Full Text PDF